Fiduciary Alliance’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1
Closed -$141 764
2023
Q2
$141 Buy
+1
New +$160 ﹤0.01% 979
2023
Q1
Sell
-1
Closed -$169 698
2022
Q4
$169 Buy
+1
New +$181 ﹤0.01% 911

Other funds holding RGEN

Fiduciary Alliance's RGEN Position: Q3 2023 in Review

Fiduciary Alliance sold out of Repligen (RGEN) in Q3 2023, closing a stake of 1 share — an estimated $141 sold.

Fiduciary Alliance first reported a position in RGEN in Q4 2022 and held it in 2 quarters. The position peaked at $169 in Q4 2022. 439 funds tracked by Wall St. Rank hold RGEN as of Q3 2023.

  • Fiduciary Alliance reported no remaining Repligen position as of Q3 2023 after selling out during the quarter.
  • Fiduciary Alliance sold 1 Repligen share in Q3 2023, an estimated $141.
  • Fiduciary Alliance first reported a position in Repligen in Q4 2022 and held it in 2 quarters.
  • Fiduciary Alliance's Repligen position peaked at $169 in Q4 2022.
  • 439 funds tracked by Wall St. Rank held Repligen as of Q3 2023.

Based on Fiduciary Alliance's 13F filing for Q3 2023, filed 18 Oct 2023.